Prevention of Future Deaths reports · 2023

William Gray

Regulation 28 report to prevent future deaths, reference 2023-0511, written 8 Dec 2023. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report8 Dec 2023
Reference2023-0511
DeceasedWilliam Gray
CoronerSonia Hayes
Coroner areaEssex
CategoryChild Death (from 2015) · Hospital Death (Clinical Procedures and medical management) related deaths
Organisation namedMid and South Essex NHS Foundation Trust
Sourcejudiciary.uk record · original PDF
Responses published6

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

REGULATION 28:  REPORT TO PREVENT FUTURE DEATHS (1) 

NOTE: This form is to be used after an inquest. 

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO: 

1.  Chief Executive Officer Mid & South Essex NHS Foundation Trust 
 Chief Executive Association of Ambulance Chief 
2. 

Executives 

3. 

 Chief Executive East of England Ambulance Service NHS 

Trust  

4.  Victoria Atkins Secretary of State for Health  
5. 

 Chief Executive Officer Essex Partnership University 

NHS Foundation Trust 

1 

2 

3 

4 

CORONER 

I am Sonia Hayes, Area Coroner, for the coroner area of Essex 

CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice 
Act 2009 and regulations 28 and 29 of the Coroners (Investigations) Regulations 
2013. 

INVESTIGATION and INQUEST 

On 9 June 2021 an investigation was commenced into the death of WILLIAM BRIAN 
KIN GRAY age 10. The investigation concluded at the end of the inquest on 22 
November 2023. The conclusion of the inquest was 1a Cardiac Arrest Secondary to 
Respiratory Arrest 1b Acute Asthma Secondary to Chronically Very Under controlled 
Asthma.  

William Gray died as a consequence of failures by healthcare professionals to recognise 
the severity and frequency of his asthma symptomatology and the consequential risk to 
his life that was obvious. William’s death was contributed to by neglect. William’s death 
was avoidable. There were multiple failures to escalate and treat William’s very poorly 
controlled asthma by healthcare professionals that would and should have saved 
William’s life. 

CIRCUMSTANCES OF THE DEATH 

William had a seven-year history of asthma and met the criteria for specialist referral. 
William’s care and treatment was sub-optimal; his asthma was poorly controlled in the 
absence of appropriate assessment and reviews. William required chest compressions 
and intramuscular adrenalin in accordance with the Joint Royal Colleges Ambulances 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Liaison Committee (JRCALC) Guidelines with oxygen for a life-threatening asthma 
attack on 27 October 2020 that saved his life. William was conveyed to Southend 
Hospital where he was discharged home four hours later with no assessment of his 
recent symptomatology and no change to his medications. Family contacted the GP 
service for advice and chased a referral to the asthma and allergy services. No changes 
were made to William’s medication until 4 November 2020 when he was prescribed a 
steroid preventer inhaler at the request of the asthma nurse and follow-up with Southend 
Hospital. William was lost to follow-up at Southend Hospital following a consultant 
appointment on 14 November 2020. The Asthma and Allergy Service comprised of 
telephone calls of no more than five minutes with no contact after 1 February 2021 until 
21 May. The GP prescribed four short doses of oral steroids for exacerbations of his 
asthma in December 2020, February, April and 19 May 2021 that were insufficient to 
effectively manage obviously poorly controlled asthma in a picture of vastly excessive 
reliever inhaler prescriptions and the absence ongoing of preventer medication.  
On 21 May 2021 the asthma nurse did not review or escalate the increased salbutamol 
inhaler use information shared. The advanced GP nurse practitioner reviewed William’s 
condition on 25 May 2021 at the request of the GP following the final prescription of 
steroids and confirmed that William’s asthma remained very poorly controlled but failed 
to escalate concerns. As a consequence of multiple failures, William suffered an 
inevitable life-threatening asthma attack on the night of 29 May 2021 and crew arrived at 
approximately 00:18. Ambulance Crew could not secure William’s airway when he went 
into respiratory arrest with a missed opportunity by ambulance crew to administer 
intramuscular adrenalin in the presence of a strong pulse that probably would have 
delayed the cardiac arrest and possibly saved his life. William went into cardiac arrest at 
approximately 00:35 with further crew on scene and chest compressions commenced. 
Intravenous adrenalin was administered at approximately 00:45 when William was in the 
ambulance and resuscitation continued until HEMS met the ambulance en-route to 
hospital. The HEMS doctor inserted an endotracheal tube and administered medications 
and William was conveyed to hospital. William had sustained a brain injury not 
compatible with life. 

5 

CORONER’S CONCERNS 

During  the  course  of  the  inquest  the  evidence  revealed  matters  giving  rise  to 
concern. In my opinion there is a risk that future deaths will occur unless action 
is taken. In the circumstances it is my statutory duty to report to you. 

The MATTERS OF CONCERN are as follows.  –  

Mid & South Essex NHS Foundation Trust  

(1) Experienced hospital paediatric doctors all gave evidence that they were unaware 
that administration of intramuscular adrenaline by paramedics is part of the Joint Royal 
Colleges Ambulances Liaison Committee JRCALC protocol for life-threatening asthma. 
The beneficial effects of the administration adrenalin was not considered, William’s 
presentation on arrival at hospital was falsely reassuring.  

Association of Ambulance Chief Executives  

(2) Life threatening childhood asthma is a rare occurrence for ambulance paramedics 
and the Joint Royal Colleges Ambulances Liaison Committee (JRCALC) Guidelines sets 
out treatment for it, however as paramedics rarely attend: 

a.  Clarity is required on what should be catagorised as a life-threatening asthma.  With 
guidance to enter the algorithm immediately to administer intramuscular adrenalin 
the purpose being to avoid cardiac arrest. Paramedics are more familiar with 
administration of intravenous adrenalin during resuscitation once cardiac arrest has 

2 

 
 
 
 
 
 
 
 
 
 
 
 occurred 

b.  does not contain clear guidance or advice on what to do when crew cannot 

ventilate, cannot oxygenate, or  

c.  when to abort repeated unsuccessful attempts to secure an airway and progress to 

hospital 

inflation pressure being a potential cause of failure to secure a paediatric airway   

d. 
        adjunct in life threatening asthma the consequence of this being increased  
        ventilations pressure would be required 

East Of England NHS Ambulance Trust  

(3)  Learning  and  sharing  lessons  learned  is  a  function  of  investigation.  The  Trust 
investigation report did not: 

(a)  scrutinise  the  ambulance  attendance  to  William  on  27  October  2020  in 
comparison  to  the  attendance  on  29  May  2021  and  missed  an  opportunity  to 
understand: 

i. 

the  importance  of  the  administration  of  adrenalin  during  a  life-threatening 
asthma  attack  in  accordance  with  the  JRCALC  guidelines  and  that  there 
may  be  additional  training  needs.  Two  paramedics  attended  both  on    27 
October  2020  and  29  May  2021  but  did  not  consider  the  administration  of 
intramuscular adrenalin on the second occasion.    

ii.  Whilst life-threatening asthma in children is an extremely rare call, the same 
two  paramedics  attended  on  27  October  and  29  May  and  initial  treatment 
given differed during a life-threatening asthma attack  

iii. 

iv. 

that ambulance crew focused on the airway to exclusion of other treatment 
options  and  did  not  recognise  the  significant  amount  of  inflation  pressures 
that  are required to manage the airway of  an  asthmatic child  in respiratory 
arrest. Crew were misled in thinking that the airway adjunct equipment was 
not the correct size as a consequence, and were swapping the adjuncts 

that the same paramedic was left managing an airway throughout the arrest 
despite  the  arrival  of  more  experienced  colleagues  that  arrived  as  backup, 
including an LMO until HEMS took over.  

The Trust did not address the issues at 3 (a) i-iv above in their annual training following 
William’s death and no alerts or learning notes have been circulated.  

(b)  East of England Ambulance NHS Trust investigation did not identify a number of 
risks and omissions its investigation of this child death: 

         i. inflation pressure being a potential cause of failure to secure a paediatric airway   
            adjunct in life threatening asthma the consequence of this being increased  
            ventilations pressure would be required 

         ii. Intramuscular adrenalin was not administered for life threatening asthma for a   
             child in respiratory arrest in accordance with JRCALC  

         iii. Intravenous adrenalin was not given or attempted when the patient went into  
             cardiac arrest in accordance with the resuscitation guidelines and Intraosseous  
             access was not attempted for a child in cardiac arrest for at least 10 minutes  
             and only when the patient was in the ambulance.  

(4) The Trust issued a Clinical Instruction on 17 September 2020 that paramedics must 

3 

 
 
 
 
 
 
 
 
 
 
 
           
 not insert endotracheal tubes as a safety measure to avoid adverse incidents as there 
was a difficulty in keeping paramedics skills up to a level of competency. Evidence was 
heard that the Trust has since revised its policy and reintroduced endotracheal 
intubation for a specialist cohort of paramedic crew: 

i.  The Trust treatment for those aged 12 and over permits endotracheal intubation 
       by those ambulance crew with specialist qualifications however, they cannot   
       intubate children under 12 who are entirely reliant on HEMS arriving in sufficient  
       time if the airway cannot be sufficiently managed. 

ii.  Essex is a large county and there are very few paramedics trained on any one  
       shift to provide endotracheal intubation 

there is a difference in provision of life-saving treatment in Essex between those 

iii. 
      over 12 and for children under 12 and HEMS is a charity with very limited  
      resource across a very large county. 

Secretary of State for Health 

(5) Training for health professionals who care for children and young people is not 
mandatory  

The National Capabilities Framework for Professionals who care for Children and 
Young People with Asthma (NHS Health Education England) contains tiers of training 
and national capabilities but is not mandatory and although it sets out in the ‘Forward’ to 
that document that: 

    “The UK has some of the highest prevalence, emergency admission and death rates for 
     childhood asthma in Europe and outcomes are worse for children and young people 
     living in the most deprived areas. A number of reports produced in recent years make key 
     recommendations for all professionals involved in the care of children and young people with  
     asthma. The National Review of Asthma Deaths and the more recent Healthcare Safety  
     Investigation Branch report highlight the need for healthcare professionals to be competent in  
     the management of children and young people with asthma. 
     The development and implementation of the National Capabilities Framework for Professionals  
     who care for Children and Young people with Asthma, aims to ensure that all professionals  
     involved in their care are meeting the level of competency required for their particular role in  
     the management of that child or young person. The adoption of this framework will ensure that  
     competent professionals are delivering effective asthma care and will therefore drive  
     improvements in health outcomes for children and young people with asthma, as well as    
     education and training in the future.” 

and in the ‘Background’ to the document 

   “ …One successful contact with a well-trained professional may be the contact that makes the 
    difference.” 

Essex University Partnerships NHS Foundation Trust 

(6) The Asthma & Allergy Childrens and Young Persons Service (the Service) 

a. At the time of William’s initial referral to the Service in 2018 this consisted of one 
nurse for approximately 2000 children, and this increased to two nurses in November 
2020. The evidence heard is that whilst the number of nurses has increased so has the 
geographical area that the Service covers, and that there are ongoing plans to increase 
this further. The Service remains under resourced whilst attempting to expand.   

b. The Service continued to operate during the pandemic and did not introduce video 
calls when they could not make face-to-face attendances. There was no risk 
assessment of the impact on the Service, and no audit of whether this was sufficient to 
manage the Service. There is no contingency plan in place should this issue arise again.   

4 

 
 
 
 
 
 
 
 
     
 
 
 
 
 c. The Service relied on telephone contact Nurses did not speak to William although he 
was old enough to be involved in his care. 

ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I believe you 
and your organisation have the power to take such action.  

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this 
report,  namely  by  Monday  5th  February  2024.  I,  the  coroner,  may  extend  the 
period. 

Your  response  must  contain  details  of  action  taken  or  proposed  to  be  taken, 
setting out the timetable for action. Otherwise, you must explain why no action is 
proposed. 

COPIES and PUBLICATION 

I  have  sent  a  copy  of  my  report  to  the  Chief  Coroner  and  to  the  following 
Interested Persons: 

• 
•  Care Quality Commission  

 (Mother) 

I am also under a duty to send the Chief Coroner a copy of your response.  

The  Chief  Coroner  may  publish  either  or  both  in  a  complete  or  redacted  or 
summary  form.  He  may  send  a  copy  of  this  report  to  any  person  who  he 
believes may find it useful or of interest. You may make representations to me, 
the coroner, at the time of your response, about the release or the publication of 
your response by the Chief Coroner. 

6 

7 

8 

9 

8 December 2023                   

HM Area Coroner for Essex Sonia Hayes 

5

Responses

6 responses published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from Association of Ambulance Chief Executives (PDF)
Association of Ambulance Chief Executives 
25 Farringdon Street 
London 
EC4A 4AB 

30 January 2024 

HM Area Coroner for Essex  
Sonia Hayes 

Dear Ms Hayes 

WILLIAM GRAY (DECEASED) 

I am writing in response to the preventing future deaths report we received at the Association of 
Ambulance Chief Executives (AACE) dated 8th December 2023, and I respond as the Director of 
Operational Development and Quality Improvement on behalf of the AACE. On behalf of AACE, I would 
also like to extend our sincere condolences to the family of William. 

It may be helpful for us to explain that AACE is a private company owned by the English and Welsh NHS 
ambulance services. Its purpose is to support its members, UK NHS ambulance services, in the 
implementation of national agreed policy and to act as an interface, where appropriate at a national level, 
between them and their stakeholders. It is a company owned by NHS organisations and possesses the 
intellectual property rights of the Joint Royal Colleges Ambulance Liaison Committee UK ambulance 
service clinical practice guidelines (the “JRCALC guidelines”). AACE is not constituted to mandate or 
instruct ambulance services however it has national influence via the regular meetings of ambulance chief 
executives and chairs along with a network of national specialist sub-groups.  

With regard to your matter of concern relating to ambulance services: 

Life threatening childhood asthma is a rare occurrence for ambulance paramedics and the 
Joint Royal Colleges Ambulances Liaison Committee (JRCALC) Guidelines sets out 
treatment for it, however as paramedics rarely attend: 

a. Clarity is required on what should be categorised as a life-threatening asthma. With 
guidance to enter the algorithm immediately to administer intramuscular adrenalin the 
purpose being to avoid cardiac arrest. Paramedics are more familiar with administration of 
intravenous adrenalin during resuscitation once cardiac arrest has occurred.’ 

b .Does not contain clear guidance or advice on what to do when crew cannot ventilate, 
cannot oxygenate. 

c.    or when to abort repeated unsuccessful attempts to secure an airway and progress to 
hospital 

d.  Inflation pressure being a potential cause of failure to secure a paediatric airway adjunct 
in life     threatening asthma the consequence of this being increased ventilations pressure 
would be required. 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 Thank you for bringing these tragic circumstances to our attention and allowing us to consider how our own 
guidance might be improved. The JRCALC guidelines are advisory and have been developed to assist 
paramedics make decisions about the management of the patient’s condition , including treatments and to 
support clinical practice. 

The advice is intended to support the clinician’s decision-making process and is not a substitute for sound 
clinical judgement. We recognise that the guidelines cannot always contain all the information necessary 
for determining appropriate care and cannot address all individual situations; therefore, we expect that 
paramedics using JRCALC guidelines ensure they have the appropriate knowledge and skills to enable 
suitable interpretation. JRCALC guidance is not intended to be a full medical textbook, and therefore 
underpinning knowledge around conditions such as asthma is expected, and this should include an 
understanding of the pathophysiology of asthma and how the condition affects the airways.  

JRCALC provides specific guidance for asthma in adults and children. Many of the guidelines contain key 
points, and included in the key points in the asthma guidance are: 

•  Asthma is a common life-threatening condition. 
• 
Its severity is often not recognised. 
•  A silent chest is a pre-terminal sign. 
•  Bronchodilators are the mainstay of treatment. 
• 
•  Clinical assessment should determine the severity of the asthma attack. 
•  Consider magnesium in life-threatening asthma not improving with continuous nebulised 

Ipatropium bromide should be considered in severe cases. 

salbutamol. 

•  Consider adrenaline for life-threatening asthma continuing to deteriorate with continuous nebulised 

salbutamol. 

The guideline highlights that that there should be a specific assessment of the severity of the asthma 
attack and contains a table describing the features of severity. It also contains an algorithm detailing how to 
manage an asthma attack depending on the severity. It does also  detail when to consider administering 
adrenaline.  

At the JRCALC committee meeting on 9th January 2024 we discussed this preventing future deaths report 
as an agenda item. A decision was made to undertake a review of the guideline and particularly the  
assessment and management algorithm and decide if it can be made clearer and have more detail and 
emphasis on the use of adrenaline.  

With regard to airway management, the JRCALC guidelines  provide guidance in the resuscitation sections 
on managing an airway and using a stepwise approach including considering when to progress from one 
airway technique to another. As you will be aware, airway management is a practical skill and needs 
regular training and practice which is beyond the scope of JRCALC to mandate. It is for the individual 
clinicians  and the organisation that they work for to ensure the competency of airway skills and agree 
which advanced airway skills and airway adjuncts should be used. In managing a difficult airway such as in 
the case of life threatening or near fatal asthma, part of the training of  a paramedic would be to understand 
the potential difficulties that may be encountered and the strategies that may need to be considered in 
each individual case. This includes decisions about calling for enhanced help and urgent transport to 
definitive care. 

We are aware that most ambulance services do not support intubation by all paramedics. We know that it 
is a skill used by some paramedics, mainly where they have received additional training and are able to 
maintain their competency. Our guidance states in relation to tracheal intubation: 

2 

 
 
 
 
 
 
 
 
 
 
 The tracheal tube is a challenging airway device to insert successfully and requires both 
adequate initial training and ongoing practice. Paramedics must ensure that they have 
appropriate competence to undertake it safely and that this skill has been regularly updated 
and evidenced through maintaining an airway skills log. 
There is no evidence that patient outcome is any better following tracheal intubation 
compared with any other type of airway. 
Where, as a paramedic, the governance system you work within allows you to intubate, you 
should only do so if you have maintained your skills and have evidence of self-audit with a 
success rate of greater than 95% success rate within two attempts. 

In the advanced life support (ALS) for children guidance it states: 

During ALS, the priority remains the delivery of high-quality chest compressions and effective 
ventilations with high-flow oxygen. Particular focus should be to ensure reversal of any 
hypoxia. 

Supraglottic airways (SGAs) may be considered if BVM (bag valve mask) ventilation is 
ineffective. 

Intubation is rarely indicated and should only be undertaken by those with appropriate skills, 
according to local protocols and only when waveform capnography is available. 

In summary, we have reviewed our JRCALC guidance in relation to the matters of concern you have raised 
and will now review the asthma guideline and make changes if these are deemed to be required. We will 
also share the details of your concerns with our national ambulance service medical directors’ group 
(NASMeD). They have regular meetings where learning from incidents and preventing future death reports 
are discussed. We will suggest that medical directors of the UK ambulance services consider if they 
believe any further education or awareness is needed for their clinicians, in relation to airway management 
and asthma and particularly in relation to considering administering adrenaline in asthma.  

I hope this response has adequately addressed the concerns that you have raised. If you have any further 
questions, please do not hesitate to get in touch.  

Yours sincerely 

Director of Operational Development and Quality Improvement 

3
Response from Department of Health and Social Care (PDF)
Andrew Stephenson MP 
Minister of State 

39 Victoria Street 
London 
SW1H 0EU 

19th February 2024 

Ms Sonia Hayes,  

HM Area Coroner for Essex, 

Ground floor 
Seax House 
Essex County Council 
Victoria Road South 
Chelmsford 
CM1 1LX 

Dear Ms Hayes,  

Thank you for your letter of 11 December 2023 about the death of William Brian Kin 
Gray.  I am replying as Minister with responsibility for education and training of the 
NHS workforce.    

Firstly, I would like to say how saddened I was to read of the circumstances of William 
Gray’s death and I offer my sincere condolences to the family and loved ones. The 
circumstances your report describes are very concerning and I am grateful to you for 
bringing these matters to my attention.  

Employers in the health system are responsible for ensuring that their staff are trained 
to the required standards to deliver appropriate treatment for patients and for ensuring 
that  staff have  appropriate  time  to undertake  continuous  professional development. 
Health  Education  England  (now  part  of  NHS  England)  published  The  National 
Capabilities  Framework  for  Professionals  who  care  for  Children  and  Young  People 
with Asthma with a range of training programmes for people to use.  

 
 
 
 
 
 
 
 
 
 
 
 The Framework is aimed at anybody who may encounter a child or young person with 
asthma,  including  healthcare  professionals.    As  you  note,  it  sets  out  a  range  of 
capabilities, which can be achieved for most of the tiers through structured education 
programmes. Individuals working at tiers 4 and 5 may choose to complete a portfolio 
of evidence instead. Several national courses have been designed and accredited to 
meet the capabilities for tiers 1 to 4.    

In general terms, the standard of training for health care professionals is the 
responsibility of the health care independent statutory regulatory bodies who set the 
outcome standards expected at undergraduate level and approve courses and 
Higher Education Institutions to write and teach the curricula content that enables 
their students to meet the regulators outcome standards.  The Health and Care 
Professions  Council and Nursing and Midwifery Council are the regulators for 
paramedics and nurses respectively. 

Whilst not all curricula may necessarily highlight a specific condition, they all 
nevertheless emphasise the skills and approaches a Health Care Practitioner must 
develop in order to ensure accurate and timely diagnoses and treatment plans for 
their patients, including for asthma. 

UK medical schools determine the content of their own curricula. The delivery of 
these undergraduate curricula have to meet the standards set by the General 
Medical Council (GMC), who then monitor and check to make sure that these 
standards are maintained. The standards require the curriculum to be formed in a 
way that allows all medical students to meet the GMC’s Outcomes for Graduates by 
the time they complete their medical degree, which describe knowledge, skills and 
behaviour they have to show as newly registered doctors.  

The curricula for postgraduate specialty training is set by the Academy of Medical 
Royal Colleges for foundation training, and by individual Royal Colleges and faculties 
for specialty training. The GMC approves curricula and assessment systems for 
each training programme. Curricula emphasise the skills and approaches that a 
doctor must develop in order to ensure accurate and timely diagnoses and treatment 
plans for their patients. 

Employers in the health system are responsible for ensuring that their staff are 
trained to the required standards to deliver appropriate treatment for patients. 

I hope this response is helpful. Thank you for bringing these concerns to my attention.  

 
 
 
 
 
 
 
 
 Kind regards, 

THE RT HON ANDREW STEPHENSON CBE MP 
MINISTER OF STATE
Response from East of England Ambulance Service (PDF)
'•'1:kj

East of England 
Ambulance Service 
NHS Trust 

East of England Ambulance Service NHS Trust 
Wh iting Way 
Melbourn 
Cambridgeshire
SG86NA 

HM  Coroner Sonia  Hayes 
Area  Coroner for Essex 
By email 

29  January 2024 

Dear Ms  Hayes 

I am  writing  further to  the  inquest into the  death  of William  Brian  Kin  Gray, which  concluded  on 
22  November  2023.  I  understand  that  you  heard  evidence  from  a  number  of Trust  witnesses 
during the  inquest.  Following this you  made a Regulation 28  Preventing Future Death report on  8 
December 2023 outlining your concerns and  I have responded to these  below: 

Learning  and  sharing 
investigation report did  not: 

lessons 

learned 

is  a  function  of  investigation.  The  Trust 

(a) scrutinise the  ambulance attendance to William  on  27  October 2020  in  comparison 

to  the  attendance on  29  May 2021  and  missed an opportunity to  understand: 

i. 

the  importance  of  the  administration  of  adrenalin  during  a  life-threatening 
asthma attack in  accordance with the  JRCALC guidelines and that there  may be 
additional  training  needs.  Two  paramedics  attended  both  on  27  October 2020 
and  29  May  2021  but  did  not  consider  the  administration  of  intramuscular 
adrenalin on  the  second occasion. 

ii.  Whilst life-threatening asthma in  children is  an  extremely rare  call , the same two 
paramedics  attended  on  27  October  and  29  May  and  initial  treatment  given 
differed during a life-threatening asthma attack. 

It was clear from  the  evidence given  at the  inquest and  from  the  crew's  previous  attendance  to 
this  patient  that  adrenaline  could  have  been  administered  to  William  in  accordance  with  the 
JRCALC  guidelines. The  crew  were  aware  of the  guidelines  and  this  is  not  disputed.  It  was  a 
challenging and  busy scene and this contributed to  the crew omitting to  administer adrenaline. 

The  Trust  has  completed  work  over the  past  year  in  relation  to  human  factors  and  how these 
influence  behaviour at work  in  a way which  can  affect  safety.  Posters  have  been  disseminated 
across the  region  and  pop-up  banners  are  being  used  at  engagement events  across the  Trust. 
The  Patient  Safety  Team  have  also  included  information  around  human  factors  in  the  Safety 
Matters Newsletter, which  is  a monthly  publication  shared  with  all  staff,  and  released  a podcast 
last  year on  human  factors . There  are  two  training  modules available  to  staff, which  have  been 
publicised as well. 

In order to  raise further awareness, a case study will  be  included in the Safety Matters Newsletter 
and  the  Trust's  pharmacist  will  include  information  around  the  benefits  of IM  adrenaline  being 
administered  to  a  patient  with  life-threatening  asthma  together  with  the  appropriate  point  to 
administer this.  The  aim  is  to  demonstrate to  staff the  physiological  benefits  of administering  in 
this situation . 

Chief Executive: 
Chair: Mrundal Sisodia 
www.c'<-stamL .nhs.uk 

#WeAreEEAST 

 
 For adult patients, the Trust used to  have access to pre-filled  IM  adrenaline syringes and a report 
will  be  taken  to  the  Trust's  Medicines  Management Group  for consideration.  Paediatric  patients 
are not administered with a set dose and the clinician needs to draw this up separately dependant 
on  age/weight in  line with  JRCALC guidance. 

iii. 

That the  ambulance crew focused  on  the  airway to  exclusion  of other treatment 
options  and  did  not recognise  the  significant amount of inflation  pressures that 
are  required  to  manage  the  airway  of  an  asthmatic  child  in  respiratory  arrest. 
Crew  were  misled  in  thinking  that  the  airway  adjunct  equipment  was  not  the 
correct size as a consequence and were swapping the  adjuncts. 

Information pertaining to  the difficulties securing airways for asthmatic patients will  be shared  in 
the  Safety Matters newsletter as part of the case study. The Trust has also contacted the 
Asthma and  Lungs UK charity to  establish  if we could  undertake shared  learning or work with 
them to  produce further resources for our staff. 

iv. 

that  the  same  paramedic  was  left  managing  an  airway  throughout  the  arrest 
despite  the  arrival  of  more  experienced  colleagues  that  arrived  as  backup, 
including a Local  Operations Manager until  HEMS took over. 

Attendance to  a paediatric asthma  attack that  leads to  cardiac arrest is  very rare  for ambulance 
clinicians  to  experience.  A  handover should  be  undertaken  when  new clinicians  are  arriving  on 
scene and  this  is the  responsibility of both  parties to engage in  line with  human factor training.  A 
case  study of our attendance to  William  will  be  included  in  the  Safety Matters  newsletter,  which 
will  include further inform_ation  relating  to  the  importance of handover communication  when  new 
clinicians arrive on  scene. 

The  Trust did  not address  the  issues  at  3 (a)  i-iv  above  in  their annual  training  following 
William's death and  no alerts or learning notes have been circulated. 

(b)  East of England Ambulance NHS Trust investigation did not identify a number of 
risks  and omissions in  its  investigation of this child death: 

i.  inflation  pressure being a potential cause of failure to secure a paediatric airway 

adjunct in  life threatening asthma the consequence of this  being  increased 
ventilations pressure would  be  required 

ii.  Intramuscular adrenalin was  not administered for life threatening asthma for a 

child  in  respiratory arrest in  accordance with JRCALC 

iii. Intravenous adrenalin was  not given or attempted when  the  patient went into 

cardiac arrest in  accordance with the  resuscitation guidelines and  lntraosseous 
access was  not attempted for a child  in  cardiac arrest for at least 10  minutes 
and  only when the  patient was  in the  ambulance. 

The Trust has  recently recruited  six  Resuscitation  Officers across the  region.  Part of their role  is 
to  improve  our response  to  critically  unwell  patients  by  designing  a  new  cardiac  arrest  training 
programme  and  provide  coaching  to  clinicians.  The  delay  in  administering  IV  adrenaline  and 
gaining  intraosseous  access  has  been  brought  to  their attention  and  will  be  included  as  part  of 
this updated training . 
Chief Executive:
Chair: Mrundal Sisodia 
www.€astan,L .nhs.uk 

#WeAreEEAST 

 
 In  terms of i)  and  iii),  I have set out the actions the Trust is taking above. 

(4) The Trust issued a Clinical  Instruction on  17 September 2020 that paramedics must 
not insert endotracheal tubes as a safety measure to  avoid  adverse incidents as there 
was a difficulty in  keeping  paramedics skills up  to  a level of competency.  Evidence was 
heard that the Trust has since revised  its  policy and  reintroduced endotracheal 
intubation for a specialist cohort of paramedic crew: 

i. 

The Trust treatment for those aged  12 and over permits endotracheal intubation 

by those ambulance crew with  specialist qualifications however, they cannot 
intubate children  under 12 who are entirely reliant on  HEMS arriving  in  sufficient 
time  if the airway cannot be  sufficiently managed. 

ii. 

Essex is  a large county and  there are very few  paramedics trained on  any one 

shift to  provide endotracheal intubation 

iii. 

there  is  a difference in  provision of life-saving treatment in  Essex between 
those over 12 and for children under 12 and  HEMS is  a charity with  very limited 

resource across a very large county. 

There  is  strong  scientific  evidence  that  endotracheal  intubation,  like  any  skill,  requires  regular 
exposure  and  practice  to  ensure  proficiency  in  those  moments  when  it  is  needed  and  there  is 
evidence of poor success rates without regular exposure and  practice.  On average,  research  has 
shown that the average paramedic may be required to intubate an adult patient between 1-3 times 
a year.  It has also shown that the need to  intubate a child  is even less than that and  is about once 
every three to four years. These numbers are not sufficient to  maintain competency and  the  skill 
was removed for patient safety reasons. This is in  line with other NHS Ambulance Services across 
the  country.  The  majority  of  airways  in  both  adults  and  children  can  be  managed  without 
intubation but by the use of a Supraglottic airway. 

Currently Specialist Paramedic/Advanced  Paramedic/Consultant Paramedic roles in Critical Care 
and  HEMS teams are authorised to  intubate patients below the age of 12  in the  East of England. 
There  are  plans to  introduce Advanced  Paramedics in  Critical  Care  cars  across the  region,  one 
per Integrated Care Board  area,  as part of the advanced  practice program  roll  out. 

Your  report  also  referred  to  the  Serious  Incident  investigation  and  missed  opportunities  for 
learning.  Since  this  investigation,  the  Trust  has  implemented  the  Patient  Safety  Improvement 
Response  Framework,  which  was  produced  by  NHS  England  and  sets  out  the  approach  to 
developing  effective  patient  safety  systems  and  learning  from  these  incidents.  The  approval 
process for identifying actions from  patient safety incidents is  now more  robust  in  that an  Action 
Setting  Group meets fortnightly to  review incident reports and  set appropriate actions. 

I hope this  provides you  with  assurance  in  relation to the  actions the Trust is taking  in  relation to 
this sad event and  I am happy to  provide a further update on  these actions in the coming  months. 
Please do  not hesitate to  contact me  should  you  require any further information. 

Chief Executive 
Chief Executive: 
Chair: Mrundal Sisodia 
www.(astamb .nhs.uk 

#WeAreEEAST
Response from Essex Partnership University NHS Foundation Trust 1 (PDF)
02 February 2024 

Private and Confidential  
Ms Sonia Hayes 
HM Area Coroner for Essex Coroner’s Office 
Seax House 
Victoria Road 
Chelmsford 
CM1 1QH 

Chief Executive Office 
The Lodge 
Lodge Approach 
Wickford 
Essex 
SS11 7XX 

Dear Ms Hayes 

Master William Brian Kin Gray (RIP) 

I write to set out the Trust’s formal response to the report made under paragraph 7, Schedule 
5, of the Coroners and Justice Act 2009 and regulations 28 and 29 of the Coroners 
(Investigations) Regulations 2013, dated 8th December 2023 in respect of the above, which 
was issued following the inquest into the death of William Gray (RIP) . 

I would like to begin by extending my deepest condolences to William Gray’s family. The Trust 
sympathises with their very sad loss of their young child. 

The matters of concern as noted within the Regulation 28 Report have been carefully reviewed 
and noted. I will now respond in full to these concerns in the hope that this provides both 
yourself and William Gray’s family with comprehensive assurance of changes that have been 
made at the Trust to address the concerns you have raised. 

Concern a) The Asthma & Allergy Children’s and Young Persons Service (the Service), at the 
time of William’s initial referral to the Service in 2018 this consisted of one nurse for 
approximately 2000 children, and this increased to two nurses in November 2020. The 
evidence heard is that whilst the number of nurses has increased so has the geographical area 
that the Service covers, and that there are ongoing plans to increase this further. The Service 
remains under resourced whilst attempting to expand. 

Response: 
We agree that there were demand and capacity challenges in the service which the Trust has 
raised with local commissioning bodies over time to try to resolve. This matter was first raised 
in 2018 and continues to be discussed with the local Integrated Care Board. 

The Trust has noted the valid concerns raised by the family as well as the Court in terms of 
resource, and has again reflected on service need and the required resources in order to meet 
demand. 

In line with the evidence presented as part of this Inquest, the Trust had a 1.0 whole time 
equivalent (wte) Band 6 in post at the time of the incident to deliver a community specialist 
asthma and allergy service. The role had a large caseload, however the remit was narrower 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 than it is currently. The role provided telephone review assessments, face to face initial patient 
assessments in local clinics, attendance at multi- disciplinary meetings and Asthma and 
Anaphylaxis training and education to local school nurses and health visitors, as well as in 
preschool nursery settings. 

In 2018 EPUT co-hosted a South East Essex Children Asthma and Allergy system-wide 
workshop where the benefits realised by the limited service was widely recognised. 

The Commissioners agreed to support the development of a business case for additional 
investment. The service reviewed the national models of good practice and with the support of 
the Commissioner, prepared a business case for additional investment into the existing 
service. Unfortunately due to the Covid pandemic, this was delayed as the Commissioners 
were redeployed to alternative roles. Subsequently, an opportunity arose to apply to NHS 
England for pilot monies to expand the integration into primary care networks and to promote 
the ‘Asthma Friendly Schools Initiative’. The business case prepared for the expansion of the 
existing team at the previously co-hosted workshop was submitted to NHS England requesting 
an additional 8.0 wte Band 6s to deliver an enhanced service in South East Essex. In 2021 the 
service was awarded an additional 3.0 wte Band 6s to deliver a pilot in local surgeries and to 
implement the Asthma Friendly Schools Initiative. Whilst the Trust was not awarded the full 
application of 8.0 wte, we were able to recruit to 3 further roles which has had a positive effect 
on service delivery. 

The service continually endeavours to work hard to improve and deliver a responsive service 
to those who are referred to the Asthma and Allergy Service for support. Service provisions 
and compliance is monitored to ensure we continue to maintain a responsive service.  Further, 
children are safety netted via signposting to GP’s and charities such as Asthma + Lung UK and 
Allergy UK. 

Since 2018 the service has seen an increase in the complexity of need in the local population 
and observed challenges for patients and parents accessing timely support from both primary 
and secondary care. In collaboration with the Commissioner and Secondary Care, the service 
has responded to system pressures by upskilling our nurses in non-medical prescribing, Tier 4 
Asthma training and Association for Respiratory Technology & Physiology (ARTP) accredited 
Spirometry training. This has afforded the service users the option of opting to access the 
service more frequently as it is more accessible- for example for prescriptions, preventative 
inhalers, and spirometry assessments and for support to progress secondary care referrals. 

In light of the service increasing its levels of expertise, it was viewed as a one stop shop for all 
types of requests from minor to urgent, however, the service now has clearer communication 
pathways for responsibility of care according to clinical need. 

Whilst the total patient caseload has remained similar to previous years the number of patient 
contacts (face to face and non-face to face contacts) has increased substantially -by 75.5% in 
2023 compared to 2018. The service strives to remain accessible but to maintain a safe and 
efficient level of service provision, a review of the existing support issued by the ICB has been 
commenced. 

The above detail is set out in an effort to demonstrate to the Court, the acknowledgment that 
greater support is required in relation to demand, and the plans in place to address this. 

It is of note that the geographical boundaries of the area remains the same but the population 
has grown and the referral volume has increased by 75%. 

 
 
 
 
 
 
 
 
 
 Due to the close working relationship between the Service and the ICB and the ideas 
generated for service development, NHS England has awarded monies to develop and 
implement the following: 

•  The Asthma Friendly Schools training to educational staff to ensure safety of children and 

young people within school. 

•  To upskill the GP practice nurses and enhance the GP’s knowledge regarding evidenced 

based medicine management, 

•  Direct patient care will continue to be delivered and remain in South East Essex only. 

The service developed an internal service development plan and a project group with the full 
engagement and support of the ICB Commissioner, who has also been advised of the content 
of this Regulation 28 Report. 

The clinical lead nurses attend the bi-monthly Mid and South Essex Asthma and Allergy 
Network meetings (which includes attendance by the MSFT Specialist Consultant Clinical Lead 
and the Primary Care Networks Clinical Lead) to engage and collaboratively work together to 
deliver more joined up care and develop clarity and understanding of functions. The team 
participates in the East of England Asthma network comprising of a number of expert 
multidisciplinary professionals in the speciality of asthma who share best practice and ideas for 
further service development. 

Prior to this Inquest, the service had already recognised improvements were required to 
effectively and safely improve the efficacy of clinical practice and continues to do so on a daily 
basis: 

•  Reviewing the service eligibility criteria 
•  Partnership working with the integrated care system to ensure the service remit is 

understood to be a supportive specialist service and not an urgent /emergency service. 
This remains the remit of primary and secondary care. 
•  Reviewing the SOP and Service Business Continuity Plan 
•  Reviewing the care pathway with partners 
•  Remodelling the community specialist asthma service offer – with engagement from 

system partners so there is greater clarity on roles and functions of all 

•  Review of the assessment templates and proforma documents to ensure equity and 
consistency of the assessments undertaken and the documentation recorded. 

•  Review care plans, symptom management plans, and letter templates 
•  Reviewing the eligibility of the respiratory caseload 
•  Review of the rag rating criteria of the Amber/Red/black critical caseloads to ensure the 
correct process of the next steps are identified i.e. once stable referral back to primary 
care (Amber). If remains uncontrolled, despite supportive management, onwards 
escalation and referral to secondary care (red) and tertiary care (black critical 

•  The Service holds clinical supervision once a month. 
•  The Service holds Difficult Asthma Meetings with the secondary care team every 3 

months and a monthly Difficult Asthma Meeting within our team. 

•  Difficult Asthma Clinic held once a month at the hospital between the service and 

Secondary care team 

•  Continued good relationship with Secondary Care team who supports our service in 

• 

caring for the patients 
Implemented the use of video conferencing (AccuRx) to visually perform remote 
assessment, although please note this does not afford the opportunity to perform chest 
auscultation which would indicate the presence of wheeze. This method of virtual 
assessment can demonstrate the teaching of peak flow and inhaler technique and enable 

 
 
 
 
 
 assessment. 

•  Timetable of clinics encompassing face to face assessments, AccruRx and telephone 

review assessments. 

•  Dedicated appointments times pre-booked in advance to ensure parent/carer/ patient 

response uptake 

•  We are working closely with our Commissioners at MSE ICB to continue to seek 

opportunities for additional resources whilst transforming the service within current staffing 
capacity. 

Concern b) The Service continued to operate during the pandemic and did not introduce video 
calls when they could not make face-to-face attendances. There was no risk assessment of the 
impact on the Service, and no audit of whether this was sufficient to manage the Service. 
There is no contingency plan in place should this issue arise again 

Response: 
The Children’s Asthma and Allergy Service have learnt many lessons from the practices 
undertaken during the pandemic and recognise video consultations could have benefitted 
patients at the time and may have helped improve the review assessments and important 
patient observations, and the service regrets that AccuRx (video consultation platform) was not 
deployed earlier. 

Following a successful pilot of the AccuRx, the service has now implemented its use and 
blended this into the timetable of review assessments, offering service users an initial face to 
face clinic assessment, followed by a review assessment utilising AccuRx. With the option of 
an additional telephone review assessment. The app helps improve communication between 
the Service and service users. The patient image feature in AccuRx is designed to enable 
patients to attach images to provide clinicians with the additional information to inform their 
care. The Business Continuity Plan has been updated which now includes the use of video 
consultations and alongside new and additional aerosol generating safe venues for face to 
face assessments such as the bespoke Clinician at Rochford Hospital and specially identified 
clinic spaces in primary care settings risk assessed to be covid secure. The Standard 
Operating Procedure (SOP) and Business Continuity Plan now include clarity on when video 
consultations should be considered for use: 

The service criteria for utilising AccuRx is the following; 

•  To be used as the preferred contact following the initial assessment. 
•  Any child/young person where there are concerns regarding inhaler or peak flow 

technique 

•  Any child/young person where there may be safeguarding concerns and face to face 

appointments are difficult to obtain. 

•  Any young person who are in their GCSE years or undertaking exams. 
•  A home where there is suspected damp/mould. 

AccuRx does not replace the importance of seeing the patient in a face to face setting 
therefore if there are concerns regarding the patient, utilising face to face clinics/home visits 
will be a priority over AccuRx or telephone clinics. 

Concern c) The Service relied on telephone contact, Nurses did not speak to William although 
he was old enough to be involved in his care 

Response: 
Current practice is to ensure all nurses request to speak with the child, if they are old enough, 
at all consultations - whether this is via telephone or video. During face to face clinic 

 
 
 
 
 
 
 
 
 appointments and home visit consultations, the Child / Young Person (CYP)’s view of their 
asthma is recorded within the voice of the child section of the electronic patient record to 
ensure all relevant parties including the GP and acute care clinicians are able to view this. 

The service model provides pre-booked appointments determined by clinical triage and acuity 
of clinical presentation, which affords service users the opportunity and dedicated time to seek 
supportive management; however this provision is flexible according to patient clinical need. 
Record keeping is undertaken at each consultation to ensure contemporaneous and accurate 
documentation, to include potential referral and escalation to secondary care. 

The outcome of all clinic consultations are documented within the patient record. Annual record 
keeping audits are undertaken monitor the consistency of assessments. This practice is further 
monitored during clinical supervisions sessions, caseload reviews and random spot checks.  

Lessons learnt 

In order to continue to learn lessons from this unfortunate tragic event, the service has 
undertaken a review of the existing capacity and demand, to identify the maximum 
effectiveness and efficiency of the current resource for the service user. Resulting in a refined 
service model with a robust patient journey either returning to primary care once stabilised or 
transition onwards to either secondary or tertiary care. As a way in which to manage risk, 
asthma care is shared amongst the multidisciplinary team, which includes primary care, 
secondary care and tertiary care. 

Whilst being mindful of not repeating the evidence provided to your Court during this Inquest, 
we respectfully re-iterate the assurances set out in the learning statement submitted during the 
inquest and the subsequently developed Action Plan to monitor compliance for the service 
which highlighted the following: 

a)  To ensure evidenced-based education and training for all MSE paediatric staff regarding 
medical devices involved in the management of Asthma. This was completed accordingly 
with the ward staff at Southend Hospital and then the subsequent employment of the 
acute clinical nurse specialist for asthma has continued with this for all acute paediatric 
staff. 

b)  All CYP to receive a written Asthma Action management plan at each children’s 

community Asthma & Allergy nurse consultation. The service has adopted and 
implemented the BEAT asthma/wheeze action plan. 

c)  The Children’s Community Asthma and Allergy (CAAS) referral form content has been 

reviewed and updated to provide safety netting and prioritisation or exclusion criteria. This 
has been completed and revised in accordance with the clinical lead for the integrated 
care system. 

d)  CAAS assessment of CYP medication and inhaler technique – medication storage and 

environmental factors. This is assessed at every face-to-face visit and is discussed during 
video consultation/ telephone reviews. 

e)  Upon discharge from the acute provider, an initial contact is actioned within five working 
days from hospital discharge, pending a face to face initial assessment scheduled within 
two weeks. Allocation of the Rag rating criteria to support patient directed contact 

f)  All CYP presenting to the ED with a suspected diagnosis of asthma are reviewed by the 
CAAS. The service is offered to those who have attended the ED on one occasion. 

 
 
 
 
 
 
 
 
 
 
 
 g)  Complex patients with uncontrolled asthma are reviewed by the lead paediatrician and 
CAAS at the monthly joint clinic and excellent collaborative relationships established. 

h)  The  outcome  of  all  clinic  consultations  are  documented  within  the  patient  record. 
Annual  recordkeeping  audits  are  undertaken  to  demonstrate  compliance  with  the 
recordkeeping template to ensure equity and consistency of the assessments. 

i)  Since the pilot integration of the children’s asthma and allergy service into the primary 
care   networks, all GP practices have been requested to share access of the patient 
record , which means the nurses are able to view the prescription history prescribed for 
the patient by the GP./practice nurse. 

j)  The service has developed a protocol which includes the required frequency of contacting 
patients, investigations required, symptom management and a robust guide on how to 
recognise and escalate patients who have high risk asthma. Patients/families are now 
specifically asked how many times they use their inhaler, i.e. it was previously more than 
3 times a week – This has now been amended to more than 2 times a week. Additional 
questions such as symptoms affecting their sleep and ability to take part in 
activities/exercise are also enquired. If the patient has sufficient developmental 
understanding, the Asthma Control Test score is implemented 

k)  Complex uncontrolled asthma patients who have progressed through the Amber caseload 
with minimal improvement are discussed at peer clinical supervision sessions and difficult 
asthma meetings as appropriate. Caseload reviews are undertaken with the team at three 
monthly intervals with the RAG rating allocated, in order to apply the relevant safety 
netting for the service user. 

l)  All service providers to ascertain if parents/carers are able to read written care advice or 
directions provided. Documented within the patient record and a number of translated 
care plans are available to families 

m)  Databases are compiled / reviewed of all service users who have been offered 

appointments and declined the service offer 

n)  All CAAS staff to undertake the online smoking cessation course, completed for existing 
staff members and will be provided to new starters in the event of staff recruitment. 

o)  All staff receive notification of updated nice guidance, this is circulated for information and 

the service is measured against the baseline assessment tool provided by NICE.  

p)  All new starters on induction to the services receive the relevant SOPs/ policies 

q)  To continue to develop links between universal services and the CAAS to improve 

education and training, to promote safe management, by addressing potential symptom 
management concerns/issues. Attendance at the universal services education forums is 
timetabled on a rolling programme and a database collated. 

I hope that I have provided reassurances around the steps that we have taken to address the 
issues of concern contained within your report. We know there is an acute need to embed and 
effect change, hence we will monitor the above provisions to ensure these are contributing to 
our overall aim of keeping patents safe and delivering therapeutic care. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 Please do let me know if you require any further information at this stage, including copies of 
any of the documents referred to above. 

We will await your direction before sharing a copy of this reply with the family. 

Yours sincerely 

Executive Chief Operating Officer / Deputy CEO
Response from Essex Partnership University NHS Foundation Trust (PDF)
02 February 2024 

Private and Confidential  
Ms Sonia Hayes 
HM Area Coroner for Essex Coroner’s Office 
Seax House 
Victoria Road 
Chelmsford 
CM1 1QH 

Chief Executive Office 
The Lodge 
Lodge Approach 
Wickford 
Essex 
SS11 7XX 

Dear Ms Hayes 

Master William Brian Kin Gray (RIP) 

I write to set out the Trust’s formal response to the report made under paragraph 7, Schedule 
5, of the Coroners and Justice Act 2009 and regulations 28 and 29 of the Coroners 
(Investigations) Regulations 2013, dated 8th December 2023 in respect of the above, which 
was issued following the inquest into the death of William Gray (RIP) . 

I would like to begin by extending my deepest condolences to William Gray’s family. The Trust 
sympathises with their very sad loss of their young child. 

The matters of concern as noted within the Regulation 28 Report have been carefully reviewed 
and noted. I will now respond in full to these concerns in the hope that this provides both 
yourself and William Gray’s family with comprehensive assurance of changes that have been 
made at the Trust to address the concerns you have raised. 

Concern a) The Asthma & Allergy Children’s and Young Persons Service (the Service), at the 
time of William’s initial referral to the Service in 2018 this consisted of one nurse for 
approximately 2000 children, and this increased to two nurses in November 2020. The 
evidence heard is that whilst the number of nurses has increased so has the geographical area 
that the Service covers, and that there are ongoing plans to increase this further. The Service 
remains under resourced whilst attempting to expand. 

Response: 
We agree that there were demand and capacity challenges in the service which the Trust has 
raised with local commissioning bodies over time to try to resolve. This matter was first raised 
in 2018 and continues to be discussed with the local Integrated Care Board. 

The Trust has noted the valid concerns raised by the family as well as the Court in terms of 
resource, and has again reflected on service need and the required resources in order to meet 
demand. 

In line with the evidence presented as part of this Inquest, the Trust had a 1.0 whole time 
equivalent (wte) Band 6 in post at the time of the incident to deliver a community specialist 
asthma and allergy service. The role had a large caseload, however the remit was narrower 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 than it is currently. The role provided telephone review assessments, face to face initial patient 
assessments in local clinics, attendance at multi- disciplinary meetings and Asthma and 
Anaphylaxis training and education to local school nurses and health visitors, as well as in 
preschool nursery settings. 

In 2018 EPUT co-hosted a South East Essex Children Asthma and Allergy system-wide 
workshop where the benefits realised by the limited service was widely recognised. 

The Commissioners agreed to support the development of a business case for additional 
investment. The service reviewed the national models of good practice and with the support of 
the Commissioner, prepared a business case for additional investment into the existing 
service. Unfortunately due to the Covid pandemic, this was delayed as the Commissioners 
were redeployed to alternative roles. Subsequently, an opportunity arose to apply to NHS 
England for pilot monies to expand the integration into primary care networks and to promote 
the ‘Asthma Friendly Schools Initiative’. The business case prepared for the expansion of the 
existing team at the previously co-hosted workshop was submitted to NHS England requesting 
an additional 8.0 wte Band 6s to deliver an enhanced service in South East Essex. In 2021 the 
service was awarded an additional 3.0 wte Band 6s to deliver a pilot in local surgeries and to 
implement the Asthma Friendly Schools Initiative. Whilst the Trust was not awarded the full 
application of 8.0 wte, we were able to recruit to 3 further roles which has had a positive effect 
on service delivery. 

The service continually endeavours to work hard to improve and deliver a responsive service 
to those who are referred to the Asthma and Allergy Service for support. Service provisions 
and compliance is monitored to ensure we continue to maintain a responsive service.  Further, 
children are safety netted via signposting to GP’s and charities such as Asthma + Lung UK and 
Allergy UK. 

Since 2018 the service has seen an increase in the complexity of need in the local population 
and observed challenges for patients and parents accessing timely support from both primary 
and secondary care. In collaboration with the Commissioner and Secondary Care, the service 
has responded to system pressures by upskilling our nurses in non-medical prescribing, Tier 4 
Asthma training and Association for Respiratory Technology & Physiology (ARTP) accredited 
Spirometry training. This has afforded the service users the option of opting to access the 
service more frequently as it is more accessible- for example for prescriptions, preventative 
inhalers, and spirometry assessments and for support to progress secondary care referrals. 

In light of the service increasing its levels of expertise, it was viewed as a one stop shop for all 
types of requests from minor to urgent, however, the service now has clearer communication 
pathways for responsibility of care according to clinical need. 

Whilst the total patient caseload has remained similar to previous years the number of patient 
contacts (face to face and non-face to face contacts) has increased substantially -by 75.5% in 
2023 compared to 2018. The service strives to remain accessible but to maintain a safe and 
efficient level of service provision, a review of the existing support issued by the ICB has been 
commenced. 

The above detail is set out in an effort to demonstrate to the Court, the acknowledgment that 
greater support is required in relation to demand, and the plans in place to address this. 

It is of note that the geographical boundaries of the area remains the same but the population 
has grown and the referral volume has increased by 75%. 

 
 
 
 
 
 
 
 
 
 Due to the close working relationship between the Service and the ICB and the ideas 
generated for service development, NHS England has awarded monies to develop and 
implement the following: 

•  The Asthma Friendly Schools training to educational staff to ensure safety of children and 

young people within school. 

•  To upskill the GP practice nurses and enhance the GP’s knowledge regarding evidenced 

based medicine management, 

•  Direct patient care will continue to be delivered and remain in South East Essex only. 

The service developed an internal service development plan and a project group with the full 
engagement and support of the ICB Commissioner, who has also been advised of the content 
of this Regulation 28 Report. 

The clinical lead nurses attend the bi-monthly Mid and South Essex Asthma and Allergy 
Network meetings (which includes attendance by the MSFT Specialist Consultant Clinical Lead 
and the Primary Care Networks Clinical Lead) to engage and collaboratively work together to 
deliver more joined up care and develop clarity and understanding of functions. The team 
participates in the East of England Asthma network comprising of a number of expert 
multidisciplinary professionals in the speciality of asthma who share best practice and ideas for 
further service development. 

Prior to this Inquest, the service had already recognised improvements were required to 
effectively and safely improve the efficacy of clinical practice and continues to do so on a daily 
basis: 

•  Reviewing the service eligibility criteria 
•  Partnership working with the integrated care system to ensure the service remit is 

understood to be a supportive specialist service and not an urgent /emergency service. 
This remains the remit of primary and secondary care. 
•  Reviewing the SOP and Service Business Continuity Plan 
•  Reviewing the care pathway with partners 
•  Remodelling the community specialist asthma service offer – with engagement from 

system partners so there is greater clarity on roles and functions of all 

•  Review of the assessment templates and proforma documents to ensure equity and 
consistency of the assessments undertaken and the documentation recorded. 

•  Review care plans, symptom management plans, and letter templates 
•  Reviewing the eligibility of the respiratory caseload 
•  Review of the rag rating criteria of the Amber/Red/black critical caseloads to ensure the 
correct process of the next steps are identified i.e. once stable referral back to primary 
care (Amber). If remains uncontrolled, despite supportive management, onwards 
escalation and referral to secondary care (red) and tertiary care (black critical 

•  The Service holds clinical supervision once a month. 
•  The Service holds Difficult Asthma Meetings with the secondary care team every 3 

months and a monthly Difficult Asthma Meeting within our team. 

•  Difficult Asthma Clinic held once a month at the hospital between the service and 

Secondary care team 

•  Continued good relationship with Secondary Care team who supports our service in 

• 

caring for the patients 
Implemented the use of video conferencing (AccuRx) to visually perform remote 
assessment, although please note this does not afford the opportunity to perform chest 
auscultation which would indicate the presence of wheeze. This method of virtual 
assessment can demonstrate the teaching of peak flow and inhaler technique and enable 

 
 
 
 
 
 assessment. 

•  Timetable of clinics encompassing face to face assessments, AccruRx and telephone 

review assessments. 

•  Dedicated appointments times pre-booked in advance to ensure parent/carer/ patient 

response uptake 

•  We are working closely with our Commissioners at MSE ICB to continue to seek 

opportunities for additional resources whilst transforming the service within current staffing 
capacity. 

Concern b) The Service continued to operate during the pandemic and did not introduce video 
calls when they could not make face-to-face attendances. There was no risk assessment of the 
impact on the Service, and no audit of whether this was sufficient to manage the Service. 
There is no contingency plan in place should this issue arise again 

Response: 
The Children’s Asthma and Allergy Service have learnt many lessons from the practices 
undertaken during the pandemic and recognise video consultations could have benefitted 
patients at the time and may have helped improve the review assessments and important 
patient observations, and the service regrets that AccuRx (video consultation platform) was not 
deployed earlier. 

Following a successful pilot of the AccuRx, the service has now implemented its use and 
blended this into the timetable of review assessments, offering service users an initial face to 
face clinic assessment, followed by a review assessment utilising AccuRx. With the option of 
an additional telephone review assessment. The app helps improve communication between 
the Service and service users. The patient image feature in AccuRx is designed to enable 
patients to attach images to provide clinicians with the additional information to inform their 
care. The Business Continuity Plan has been updated which now includes the use of video 
consultations and alongside new and additional aerosol generating safe venues for face to 
face assessments such as the bespoke Clinician at Rochford Hospital and specially identified 
clinic spaces in primary care settings risk assessed to be covid secure. The Standard 
Operating Procedure (SOP) and Business Continuity Plan now include clarity on when video 
consultations should be considered for use: 

The service criteria for utilising AccuRx is the following; 

•  To be used as the preferred contact following the initial assessment. 
•  Any child/young person where there are concerns regarding inhaler or peak flow 

technique 

•  Any child/young person where there may be safeguarding concerns and face to face 

appointments are difficult to obtain. 

•  Any young person who are in their GCSE years or undertaking exams. 
•  A home where there is suspected damp/mould. 

AccuRx does not replace the importance of seeing the patient in a face to face setting 
therefore if there are concerns regarding the patient, utilising face to face clinics/home visits 
will be a priority over AccuRx or telephone clinics. 

Concern c) The Service relied on telephone contact, Nurses did not speak to William although 
he was old enough to be involved in his care 

Response: 
Current practice is to ensure all nurses request to speak with the child, if they are old enough, 
at all consultations - whether this is via telephone or video. During face to face clinic 

 
 
 
 
 
 
 
 
 appointments and home visit consultations, the Child / Young Person (CYP)’s view of their 
asthma is recorded within the voice of the child section of the electronic patient record to 
ensure all relevant parties including the GP and acute care clinicians are able to view this. 

The service model provides pre-booked appointments determined by clinical triage and acuity 
of clinical presentation, which affords service users the opportunity and dedicated time to seek 
supportive management; however this provision is flexible according to patient clinical need. 
Record keeping is undertaken at each consultation to ensure contemporaneous and accurate 
documentation, to include potential referral and escalation to secondary care. 

The outcome of all clinic consultations are documented within the patient record. Annual record 
keeping audits are undertaken monitor the consistency of assessments. This practice is further 
monitored during clinical supervisions sessions, caseload reviews and random spot checks.  

Lessons learnt 

In order to continue to learn lessons from this unfortunate tragic event, the service has 
undertaken a review of the existing capacity and demand, to identify the maximum 
effectiveness and efficiency of the current resource for the service user. Resulting in a refined 
service model with a robust patient journey either returning to primary care once stabilised or 
transition onwards to either secondary or tertiary care. As a way in which to manage risk, 
asthma care is shared amongst the multidisciplinary team, which includes primary care, 
secondary care and tertiary care. 

Whilst being mindful of not repeating the evidence provided to your Court during this Inquest, 
we respectfully re-iterate the assurances set out in the learning statement submitted during the 
inquest and the subsequently developed Action Plan to monitor compliance for the service 
which highlighted the following: 

a)  To ensure evidenced-based education and training for all MSE paediatric staff regarding 
medical devices involved in the management of Asthma. This was completed accordingly 
with the ward staff at Southend Hospital and then the subsequent employment of the 
acute clinical nurse specialist for asthma has continued with this for all acute paediatric 
staff. 

b)  All CYP to receive a written Asthma Action management plan at each children’s 

community Asthma & Allergy nurse consultation. The service has adopted and 
implemented the BEAT asthma/wheeze action plan. 

c)  The Children’s Community Asthma and Allergy (CAAS) referral form content has been 

reviewed and updated to provide safety netting and prioritisation or exclusion criteria. This 
has been completed and revised in accordance with the clinical lead for the integrated 
care system. 

d)  CAAS assessment of CYP medication and inhaler technique – medication storage and 

environmental factors. This is assessed at every face-to-face visit and is discussed during 
video consultation/ telephone reviews. 

e)  Upon discharge from the acute provider, an initial contact is actioned within five working 
days from hospital discharge, pending a face to face initial assessment scheduled within 
two weeks. Allocation of the Rag rating criteria to support patient directed contact 

f)  All CYP presenting to the ED with a suspected diagnosis of asthma are reviewed by the 
CAAS. The service is offered to those who have attended the ED on one occasion. 

 
 
 
 
 
 
 
 
 
 
 
 g)  Complex patients with uncontrolled asthma are reviewed by the lead paediatrician and 
CAAS at the monthly joint clinic and excellent collaborative relationships established. 

h)  The  outcome  of  all  clinic  consultations  are  documented  within  the  patient  record. 
Annual  recordkeeping  audits  are  undertaken  to  demonstrate  compliance  with  the 
recordkeeping template to ensure equity and consistency of the assessments. 

i)  Since the pilot integration of the children’s asthma and allergy service into the primary 
care   networks, all GP practices have been requested to share access of the patient 
record , which means the nurses are able to view the prescription history prescribed for 
the patient by the GP./practice nurse. 

j)  The service has developed a protocol which includes the required frequency of contacting 
patients, investigations required, symptom management and a robust guide on how to 
recognise and escalate patients who have high risk asthma. Patients/families are now 
specifically asked how many times they use their inhaler, i.e. it was previously more than 
3 times a week – This has now been amended to more than 2 times a week. Additional 
questions such as symptoms affecting their sleep and ability to take part in 
activities/exercise are also enquired. If the patient has sufficient developmental 
understanding, the Asthma Control Test score is implemented 

k)  Complex uncontrolled asthma patients who have progressed through the Amber caseload 
with minimal improvement are discussed at peer clinical supervision sessions and difficult 
asthma meetings as appropriate. Caseload reviews are undertaken with the team at three 
monthly intervals with the RAG rating allocated, in order to apply the relevant safety 
netting for the service user. 

l)  All service providers to ascertain if parents/carers are able to read written care advice or 
directions provided. Documented within the patient record and a number of translated 
care plans are available to families 

m)  Databases are compiled / reviewed of all service users who have been offered 

appointments and declined the service offer 

n)  All CAAS staff to undertake the online smoking cessation course, completed for existing 
staff members and will be provided to new starters in the event of staff recruitment. 

o)  All staff receive notification of updated nice guidance, this is circulated for information and 

the service is measured against the baseline assessment tool provided by NICE.  

p)  All new starters on induction to the services receive the relevant SOPs/ policies 

q)  To continue to develop links between universal services and the CAAS to improve 

education and training, to promote safe management, by addressing potential symptom 
management concerns/issues. Attendance at the universal services education forums is 
timetabled on a rolling programme and a database collated. 

I hope that I have provided reassurances around the steps that we have taken to address the 
issues of concern contained within your report. We know there is an acute need to embed and 
effect change, hence we will monitor the above provisions to ensure these are contributing to 
our overall aim of keeping patents safe and delivering therapeutic care. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 Please do let me know if you require any further information at this stage, including copies of 
any of the documents referred to above. 

We will await your direction before sharing a copy of this reply with the family. 

Yours sincerely 

Executive Chief Operating Officer / Deputy CEO
Response from Mid and South Essex NHS Foundation Trust (PDF)
H.M Coroner’s Office 
HM Area Coroner for Essex  
Ms Sonia Hayes  
SEAX House 
Victoria Road South 
Chelmsford 
Essex 
CM1 1QH 

   29 January 2024 

Dear Ms Hayes 

Regulation 28 Report- Master William Gray 

I  write  further  to  your  Regulation  28  Report  to  Prevent  Future  Deaths  (PFDR)  dated  8 
December 2023. 

I have been appraised of the Inquest findings in relation to Master William Gray, and your 
concerns relevant to our Trust contained within the PFDR report as follows: 

“Mid and South Essex NHS Foundation Trust 

(1) Experienced hospital paediatric doctors all gave evidence that they were unaware that 
administration  of  intramuscular  adrenaline  by  paramedics  is  part  of  the  Joint  Royal 
Colleges  Ambulances  Liaison  Committee  JRCALC  protocol  for  life-threatening 
asthma.  The  beneficial  effects  of  the  administration  adrenalin  was  not  considered, 
William’s presentation on arrival at hospital was falsely reassuring.” 

The  Inquest  findings  in  this  tragic  case  have  highlighted  the  need  for  our  training  to 
specifically  include  the  potential  impact  of  pre-hospital  resuscitation  measures  on  our 
patients. Following the Inquest conclusion in November 2023, our clinicians immediately 
shared  the  learning  with  their  teams  to  raise  awareness  of  the  JRCALC  protocol  on 
managing severe asthma in children, and since then, a plan has been devised for wider 
learning. 

  Consultant  Paediatrician,  who  you  will  be  aware  was  a  witness  at  the 
Inquest  hearing  for  Master  Gray,  has  been  collaborating  with  colleagues  to  produce 
training  materials and  a  robust  plan  to  train  medical  and  nursing  staff.  Attached  to  this 
letter is a copy of the slides that will be used to deliver the first training session to staff on 
30 January 2024, ‘Understanding medicines in asthma’. Slide ten will focus specifically on 
the role of Adrenaline in treating acute asthma, both in-hospital and pre-hospital settings. 

 
      
 
 
 
 
 
 
 We  recognise  that  this  training  must  be  repeated  and  refreshed  to  capture  new  staff 
joining/moving  across  specialties.  We  must  also  keep  abreast  of  clinical  developments 
and  any  changes  to  protocols/guidance.  Therefore,  this  training  will  be  reviewed  and 
repeated at least on a quarterly basis, and the training attendance records will be kept 
monitoring compliance. 

In addition to this, a comprehensive email was sent to consultants and junior medical staff 
regarding the use of Adrenaline in pre-hospital asthma resuscitation by ambulance crew, 
and  the  potential  impact  it  has  when  patients  are  assessed  at  the  hospital.  The  email 
reminded the clinicians that where Adrenaline has been administered out of hospital, the 
patient should remain in hospital for detailed review and assessment for a minimum of 12-
24 hours to facilitate planning of further management. Please see attached email of 10 
January 2024 for your reference. 

These actions together with our Serious Incident Investigation action plan will ensure 
that staff are fully aware of potential out of hospital use of Adrenaline for not only life-
threatening Asthma, but also Cardiorespiratory arrest in both Asthma and Anaphylaxis. 

We  appreciate  this  opportunity  to  demonstrate  further  learning,  and  I  can  personally 
assure you that we are absolutely committed to improving the safety of our patients. 

If you have any further concerns or you would like to discuss this case further, please do 
not hesitate to contact me. 

Yours sincerely 

Chief Executive 
Mid and South Essex NHS Foundation Trust 

Enc. ‘Understanding medicines in asthma’ slide deck 
         Copy email sent to staff 10.01.2024 

Cc.  CQC, ICB & Southend Safeguarding Partnership (SSP)

Related reports

Other reports by Sonia Hayes

See all →

More reports categorised “Child Death (from 2015)”

See all →

Track Mid and South Essex NHS Foundation Trust

See every Prevention of Future Deaths report matching Mid and South Essex NHS Foundation Trust, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.